Search for: "Nemours Corp. v. United States" Results 41 - 56 of 56
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 Jul 2010, 5:46 am by Marie Louise
(Docket Report) District Court Delaware: Delay seeking inventor’s deposition sinks inequitable conduct defense: MagSil Corp. et al v. [read post]
23 Jan 2015, 9:30 am
Bayer Corp., 727 F.3d 300 (3d Cir. 2013), and Marcus v. [read post]
16 Jan 2017, 5:44 pm by Dennis Crouch
”) Post Grant Admin: Oil States Energy Services, LLC v. [read post]
19 Jul 2007, 1:47 pm
Kerr Corp., 418 F.3d 583, 591 (6th Cir. 2005) (OTC product) (applying Tennessee law); Ackley v. [read post]
26 May 2015, 7:42 am
  As of the time of trial, the state of the art did not include a genetic marker for SJS/TEN. [read post]
26 Feb 2011, 3:47 pm
Cir. 1996) ("The nonobviousness of the accused device, evidenced by the grant of a United States patent, is relevant to the issue of whether the change therein is substantial. [read post]
25 Apr 2015, 11:03 am by Schachtman
Third, the Manual authors state that the doubling argument assumes the “[n]onacceleration of disease. [read post]
9 Apr 2009, 9:27 am
(Promote the Progress) N D Illinois one step closer to adopting patent rules (Peter Zura's 271 Patent Blog) Innovate Texas Foundation launched to accelerate state’s IP commercialisation (Technology Transfer Tactics) Special Masters a [read post]
23 Dec 2023, 7:16 pm by admin
Not only was the statement wrong in 1993, when the Supreme Court decided the famous Daubert case, it was wrong 20 years later, in 2013, when the United States Food and Drug Administration (FDA) approved  Diclegis, a combination of doxylamine succinate and pyridoxine hydrochloride, the essential ingredients in Bendectin, for sale in the United States, for pregnant women experiencing nausea and vomiting.[16] The return of Bendectin to the market, although under… [read post]
9 Oct 2008, 4:28 am
Take a look at the illustrations in the draft itself for what it's intended to do….Actually, you can't - unless you buy the thing from the ALI publications unit. [read post]